Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:9-14
Published online before print December 6, 2004, doi: 10.1161/01.HYP.0000151325.83008.b4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
45/1/9    most recent
01.HYP.0000151325.83008.b4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahmouni, K.
Right arrow Articles by Mark, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahmouni, K.
Right arrow Articles by Mark, A. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
*Nutrition
*Obesity
Related Collections
Right arrow Obesity
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies

(Hypertension. 2005;45:9.)
© 2005 American Heart Association, Inc.


Hypertension Highlights

Obesity-Associated Hypertension

New Insights Into Mechanisms

Kamal Rahmouni; Marcelo L.G. Correia; William G. Haynes; Allyn L. Mark

From the Specialized Center of Research in Hypertension Genetics, Cardiovascular Center, the Department of Internal Medicine and the General Clinical Research Center, University of Iowa, Iowa City.

Correspondence to Kamal Rahmouni, PhD, Cardiovascular Research Center, 524 MRC, University of Iowa, Iowa City, IA 52242. E-mail kamal-rahmouni{at}uiowa.edu

Abstract

Obesity is strongly associated with hypertension and cardiovascular disease. Several central and peripheral abnormalities that can explain the development or maintenance of high arterial pressure in obesity have been identified. These include activation of the sympathetic nervous system and the renin-angiotensin–aldosterone system. Obesity is also associated with endothelial dysfunction and renal functional abnormalities that may play a role in the development of hypertension. The continuing discovery of mechanisms regulating appetite and metabolism is likely to lead to new therapies for obesity-induced hypertension. Better understanding of leptin signaling in the hypothalamus and the mechanisms of leptin resistance should facilitate therapeutic approaches to reverse the phenomenon of selective leptin resistance. Other hunger and satiety signals such as ghrelin and peptide YY are potentially attractive therapeutic strategies for treatment of obesity and its complications. These recent discoveries should lead to novel strategies for treatment of obesity and hypertension.


Key Words: hypertension, obesity • nervous system, sympathetic renal • vasculature • kidney




This article has been cited by other articles:


Home page
ChestHome page
J. Sierra-Johnson, A. Romero-Corral, V. K. Somers, L. J. Olson, and B. D. Johnson
Leptin, a Novel Predictor of Lung Function in Heart Failure
Chest, August 1, 2008; 134(2): 346 - 350.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Duprez
Cardiac Autonomic Imbalance in Pre-Hypertension and in a Family History of Hypertension
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1902 - 1903.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
C. Syme, M. Abrahamowicz, G. T. Leonard, M. Perron, A. Pitiot, X. Qiu, L. Richer, J. Totman, S. Veillette, Y. Xiao, et al.
Intra-abdominal Adiposity and Individual Components of the Metabolic Syndrome in Adolescence: Sex Differences and Underlying Mechanisms
Arch Pediatr Adolesc Med, May 1, 2008; 162(5): 453 - 461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. A. Griffin, H. Kramer, and A. K. Bidani
Adverse renal consequences of obesity
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F685 - F696.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Lurbe, I. Torro, F. Aguilar, J. Alvarez, J. Alcon, J. M. Pascual, and J. Redon
Added Impact of Obesity and Insulin Resistance in Nocturnal Blood Pressure Elevation in Children and Adolescents
Hypertension, March 1, 2008; 51(3): 635 - 641.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Biaggioni
Should We Target the Sympathetic Nervous System in the Treatment of Obesity-Associated Hypertension?
Hypertension, February 1, 2008; 51(2): 168 - 171.
[Full Text] [PDF]


Home page
PediatricsHome page
H. Zhu, W. Yan, D. Ge, F. A. Treiber, G. A. Harshfield, G. Kapuku, H. Snieder, and Y. Dong
Relationships of Cardiovascular Phenotypes With Healthy Weight, at Risk of Overweight, and Overweight in US Youths
Pediatrics, January 1, 2008; 121(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. V. Wang and P. E. Scherer
Adiponectin, Cardiovascular Function, and Hypertension
Hypertension, January 1, 2008; 51(1): 8 - 14.
[Full Text] [PDF]


Home page
HypertensionHome page
L. F. Lien, A. J. Brown, J. D. Ard, C. Loria, T. P. Erlinger, A. C. Feldstein, P.-H. Lin, C. M. Champagne, A. C. King, H. L. McGuire, et al.
Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome
Hypertension, October 1, 2007; 50(4): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. D. Lopaschuk, C. D.L. Folmes, and W. C. Stanley
Cardiac Energy Metabolism in Obesity
Circ. Res., August 17, 2007; 101(4): 335 - 347.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Cereda and A. Pietrobelli
Statins and Blood Pressure Lowering: A Claim for Ad-Hoc Trials
Hypertension, August 1, 2007; 50(2): e12 - e12.
[Full Text] [PDF]


Home page
HypertensionHome page
W.-S. Chow, B. M.Y. Cheung, A. W.K. Tso, A. Xu, N. M.S. Wat, C. H.Y. Fong, L. H.Y. Ong, S. Tam, K. C.B. Tan, E. D. Janus, et al.
Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study
Hypertension, June 1, 2007; 49(6): 1455 - 1461.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. H. Trevenzoli, M. M. R. Valle, F. B. Machado, R. M. G. Garcia, M. C. F. Passos, P. C. Lisboa, and E. G. Moura
Neonatal hyperleptinaemia programmes adrenal medullary function in adult rats: effects on cardiovascular parameters
J. Physiol., April 15, 2007; 580(2): 629 - 637.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Silver, S. D. Beske, D. D. Christou, A. J. Donato, K. L. Moreau, I. Eskurza, P. E. Gates, and D. R. Seals
Overweight and Obese Humans Demonstrate Increased Vascular Endothelial NAD(P)H Oxidase-p47phox Expression and Evidence of Endothelial Oxidative Stress
Circulation, February 6, 2007; 115(5): 627 - 637.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Sharma, I. C. Okere, M. K. Duda, D. J. Chess, K. M. O'Shea, and W. C. Stanley
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
Cardiovasc Res, January 15, 2007; 73(2): 257 - 268.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Rodriguez, A. Fortuno, J. Gomez-Ambrosi, G. Zalba, J. Diez, and G. Fruhbeck
The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism
Endocrinology, January 1, 2007; 148(1): 324 - 331.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. M. K. Volkl, D. Simm, J. Dotsch, W. Rascher, and H. G. Dorr
Altered 24-Hour Blood Pressure Profiles in Children and Adolescents with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4888 - 4895.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
P. A. van Zwieten and G. Mancia
Background and treatment of metabolic syndrome: a therapeutic challenge.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 206 - 214.
[Abstract] [PDF]


Home page
HypertensionHome page
M. Bochud, J. Nussberger, P. Bovet, M. R. Maillard, R. C. Elston, F. Paccaud, C. Shamlaye, and M. Burnier
Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome
Hypertension, August 1, 2006; 48(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. C. Okere, M. P. Chandler, T. A. McElfresh, J. H. Rennison, V. Sharov, H. N. Sabbah, K.-Y. Tserng, B. D. Hoit, P. Ernsberger, M. E. Young, et al.
Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H38 - H44.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. R. Srinivasan, L. Myers, and G. S. Berenson
Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive Subjects: The Bogalusa Heart Study
Hypertension, July 1, 2006; 48(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Maeda, S. Jesmin, M. Iemitsu, T. Otsuki, T. Matsuo, K. Ohkawara, Y. Nakata, K. Tanaka, K. Goto, and T. Miyauchi
Weight loss reduces plasma endothelin-1 concentration in obese men.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1044 - 1047.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, A. Facchini, F. Q. Trevano, R. Dell'Oro, F. Arenare, F. Tana, G. Bolla, A. Monzani, M. Robuschi, and G. Mancia
Obstructive Sleep Apnea-Dependent and -Independent Adrenergic Activation in Obesity
Hypertension, August 1, 2005; 46(2): 321 - 325.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. de Simone
Left Ventricular Hypertrophy in Blacks and Whites: Different Genes or Different Exposure?
Hypertension, July 1, 2005; 46(1): 23 - 24.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. A. Fath, R. F. Mullins, C. Searby, D. Y. Nishimura, J. Wei, K. Rahmouni, R. E. Davis, M. K. Tayeh, M. Andrews, B. Yang, et al.
Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome
Hum. Mol. Genet., May 1, 2005; 14(9): 1109 - 1118.
[Abstract] [Full Text] [PDF]